Zhangzhou Pientzehuang Pharmaceutical | 600436 - Net Income



Zz Pientze Pharmaceu reported 442.53M in Net Income for its fiscal quarter ending in June of 2025.


Net Income Change Date
Alaunos Therapeutics USD -742000 385K Dec/2024
Avita Medical AUD -11589000 3.8M Dec/2024
Cspc Pharmaceutical CNY 1.48B 927.97M Mar/2025
Dianthus Therapeutics USD -31629000 3.19M Jun/2025
Ionis Pharmaceuticals USD 123.55M 270.49M Jun/2025
IQVIA Holdings USD 266M 17M Jun/2025
Jiangsu Hengrui CNY 2.58B 702M Jun/2025
Kangmei Pharma CNY 8.4M 110.17K Jun/2025
Moderna USD -825000000 146M Jun/2025
Revvity USD 53.95M 11.71M Jun/2025
Sh Fosun Pharma CNY 937.21M 172.45M Jun/2025
Tectonic Therapeutic USD -19980000 7.61M Jun/2025
Viatris USD -4600000 3.04B Jun/2025
Wuxi Apptec CNY 4.91B 1.24B Jun/2025
Xeris Pharmaceuticals USD -1930000 52.91M Jun/2025
Zz Pientze Pharmaceu 442.53M 557.25M Jun/2025